Skip to main content
Top
Published in: International Urology and Nephrology 10/2017

01-10-2017 | Nephrology - Original Paper

Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients

Authors: Ana Paula Silva, Filipa Mendes, Luísa Pereira, André Fragoso, Rui Baptista Gonçalves, Nélio Santos, Fátima Rato, Pedro Leão Neves

Published in: International Urology and Nephrology | Issue 10/2017

Login to get access

Abstract

Purpose

The present study aimed at evaluating the relationship between Klotho levels and insulin resistance and albumin-to-creatinine ratio (ACR) in type 2 diabetic patients with CKD.

Methods

We conducted an observational, cross-sectional study in our outpatient diabetic nephropathy clinic from 2014 to 2016, enrolling a total of 107 type 2 diabetic patients with stage 2–3 CKD, with a mean age of 59 years. Several clinical and laboratorial parameters were evaluated, including those related to mineral and carbohydrate metabolism.

Results

The mean eGFR at baseline was 53.2 mL/min, and the mean levels of ACR and Klotho were 181.9 µg/mg and 331.1 pg/m, respectively. In the simple linear regression model, Klotho levels were correlated with age, phosphorus, PTH, ACR, HOMA, IL-6, FGF-23, OxLDL, eGFR and vitamin D levels. Applying a multivariate linear regression model, only the ACR, HOMA-IR, FGF-23 and vitamin D independently influenced the Klotho levels. In the generalized linear model, only the Klotho groups were statistically significant as independent variable (p = 0.007). The results show that the group 1 (<268) compared with group 3 (>440) had higher odds in the higher ACR (≥181), ORa = 3.429, p = 0.014. There were no statistically significant differences between Klotho groups 2 and 3, and the HOMA-IR obtained showed that group 1 (<268) had greater odds of HOMA-IR ≥2 when compared with group 3 (>440), ORa = 21.59, p = 0.017.

Conclusions

Our results showed that Klotho levels are influenced by FGF23, vitamin D and insulin resistance. This suggests that Klotho levels might be affected by renal function as well as having a relevant role on insulin metabolism and ACR homeostasis.
Literature
1.
go back to reference Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Ruiz-Andres O, Poveda J et al (2012) Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27(Supple 4):iv6–iv10PubMed Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Ruiz-Andres O, Poveda J et al (2012) Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27(Supple 4):iv6–iv10PubMed
2.
go back to reference Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R et al (2009) In vivo genetic evidence for Klotho-dependent, fibroblast growth factor 23 (Fgf23)—mediated regulation of systemic phosphate homeostasis. FASEB J 23:433–441CrossRefPubMedPubMedCentral Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R et al (2009) In vivo genetic evidence for Klotho-dependent, fibroblast growth factor 23 (Fgf23)—mediated regulation of systemic phosphate homeostasis. FASEB J 23:433–441CrossRefPubMedPubMedCentral
3.
go back to reference Bernheim J, Benchetrit S (2011) The potential roles of FGF-23 and Klotho in the prognosis of renal and cardiovascular diseases. Nephrol Dial Transplant 0:1–6 Bernheim J, Benchetrit S (2011) The potential roles of FGF-23 and Klotho in the prognosis of renal and cardiovascular diseases. Nephrol Dial Transplant 0:1–6
4.
go back to reference Barker SL, Pastor J, Carranza D, Quiñones H, Griffith C, Goetz R et al (2014) The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant 0:1–11 Barker SL, Pastor J, Carranza D, Quiñones H, Griffith C, Goetz R et al (2014) The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant 0:1–11
5.
go back to reference Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi Nakatani T et al (2001) Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280:1015–1020CrossRefPubMed Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi Nakatani T et al (2001) Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280:1015–1020CrossRefPubMed
8.
go back to reference Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E et al (2013) Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 83:121–128CrossRefPubMed Seiler S, Wen M, Roth HJ, Fehrenz M, Flügge F, Herath E et al (2013) Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 83:121–128CrossRefPubMed
9.
10.
go back to reference Lin Y, Sun Z (2012) Antiaging gene Klotho Enhances glucose-induced insulin secretion by up-regulating plasma membrane levels of TRPV2 in MIN6 β-cells. Endocrinology 153:3029–3039CrossRefPubMedPubMedCentral Lin Y, Sun Z (2012) Antiaging gene Klotho Enhances glucose-induced insulin secretion by up-regulating plasma membrane levels of TRPV2 in MIN6 β-cells. Endocrinology 153:3029–3039CrossRefPubMedPubMedCentral
11.
go back to reference Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A et al (2011) The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFkB. J Am Soc Nephrol 22:1315–1325CrossRefPubMedPubMedCentral Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A et al (2011) The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFkB. J Am Soc Nephrol 22:1315–1325CrossRefPubMedPubMedCentral
12.
go back to reference Lim SC, Liu JJ, Subramaniam T, Sum CF (2014) Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 15:487–490CrossRefPubMed Lim SC, Liu JJ, Subramaniam T, Sum CF (2014) Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst 15:487–490CrossRefPubMed
13.
go back to reference American Diabetes A (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–S69CrossRef American Diabetes A (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–S69CrossRef
14.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
15.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filltration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filltration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
16.
go back to reference Sawires HK, Essam RM, Morgan MF, Mahmoud RA (2015) Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Nephron 129:293–299CrossRefPubMed Sawires HK, Essam RM, Morgan MF, Mahmoud RA (2015) Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Nephron 129:293–299CrossRefPubMed
17.
go back to reference Kacso IM, Bondor CI, Kacso G (2012) Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Clin Biochem 45:1415–1420CrossRefPubMed Kacso IM, Bondor CI, Kacso G (2012) Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Clin Biochem 45:1415–1420CrossRefPubMed
18.
go back to reference Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T et al (2007) Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 104:2331–2336CrossRefPubMedPubMedCentral Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, Sasaki T et al (2007) Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 104:2331–2336CrossRefPubMedPubMedCentral
19.
go back to reference Lindberg K, Amin R, Moe OW, Hu MC, Erben RG, Östman Wernerson A et al (2014) The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol 25:2169–2175CrossRefPubMedPubMedCentral Lindberg K, Amin R, Moe OW, Hu MC, Erben RG, Östman Wernerson A et al (2014) The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol 25:2169–2175CrossRefPubMedPubMedCentral
20.
go back to reference Kocełak P, Olszanecka-Glinianowicz M, Chudek J (2012) Fibroblast growth factor 23—structure, function and role in kidney diseases. Adv Clin Exp Med 21:391–401PubMed Kocełak P, Olszanecka-Glinianowicz M, Chudek J (2012) Fibroblast growth factor 23—structure, function and role in kidney diseases. Adv Clin Exp Med 21:391–401PubMed
21.
go back to reference Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E et al (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78:679–685CrossRefPubMed Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E et al (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78:679–685CrossRefPubMed
22.
go back to reference Silva AP, Fragoso A, Neves PL (2014) Relationship of vitamin d with diabetes mellitus and diabetic nephropathy. Port J Nephrol Hypertens 28:108–118 Silva AP, Fragoso A, Neves PL (2014) Relationship of vitamin d with diabetes mellitus and diabetic nephropathy. Port J Nephrol Hypertens 28:108–118
23.
go back to reference de Zeew D, Agarwal R, AmdahM Audhya P, Coyne D, Garimella T et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study). A randomised controlled trial. Lancet 376:1543–1551CrossRef de Zeew D, Agarwal R, AmdahM Audhya P, Coyne D, Garimella T et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study). A randomised controlled trial. Lancet 376:1543–1551CrossRef
Metadata
Title
Klotho levels: association with insulin resistance and albumin-to-creatinine ratio in type 2 diabetic patients
Authors
Ana Paula Silva
Filipa Mendes
Luísa Pereira
André Fragoso
Rui Baptista Gonçalves
Nélio Santos
Fátima Rato
Pedro Leão Neves
Publication date
01-10-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1646-3

Other articles of this Issue 10/2017

International Urology and Nephrology 10/2017 Go to the issue